Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Dec 24 | PYXS Pyxis Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 1.67 | 310,000 | 517.70 k | 310,000 |
26 Nov 24 | PYXS Pyxis Oncology | Common Stock | Buy | Acquire P | Yes | No | 1.96 | 83,400 | 163.46 k | 1,199,143 |
26 Nov 24 | PYXS Pyxis Oncology | Common Stock | Buy | Acquire P | Yes | No | 2 | 5,450 | 10.90 k | 1,115,743 |
20 Jun 24 | OBIO Orchestra BioMed | Common Stock, par value $0.0001 per share ("Common Stock") | Grant | Acquire A | No | No | 0 | 5,376 | 0.00 | 21,289 |
20 Jun 24 | OBIO Orchestra BioMed | Stock Option Common Stock | Grant | Acquire A | No | No | 7.44 | 17,068 | 126.99 k | 17,068 |
26 Mar 24 | PYXS Pyxis Oncology | Common Stock | Grant | Acquire A | No | No | 0 | 328,710 | 0.00 | 1,110,293 |
29 Nov 23 | PYXS Pyxis Oncology | Common Stock | Payment of exercise | Dispose F | No | No | 1.4 | 36,949 | 51.73 k | 781,583 |